Skip to main content

Table 3 Selected auxological parameters of the patient during rhGH treatment

From: Recombinant growth hormone therapy in a girl with costello syndrome: a 4-year observation

Age [years and months] Body height [cm] Body height SDS Growth rate [cm/year] Body weight [kg] Body weight SDS BMI [kg/m2] BMI SDS Bone age [years and months]
3 years and 2 months 84 −4.94 2.10 10.7 −2.86 15.2 −0.504  
3 years 9 months (start of rhGH treatment) 84.7 −4.92 0.80 12.1 −2.60 16.9 1.005 3 years
4 years 88.9 −3.48 16.80 12.1 −2.58 15.3 0.02  
4 years 5 months 92 −3.29 7.44 13.3 −2.41 15.7 0.496  
4 years 8 months 93.3 −3.31 7.40 14 −2.28 16.1 0.508 4 years 2 months
5 years 2 months 97.8 −2.84 5.20 15.4 −1.80 16.1 0.507  
5 years 6 months 103 −2.02 9.00 16 −1.77 15.1 0.475 5 years – 5 years 9 months
6 years 1 month 107.5 −1.67 13.00 19 −0.92 16.4 0.511  
6 years 8 months 109 −1.78 2.57 a 18.4 −1.46 15.5 0.480 7 years 10 months
7 years 2 months 115 −1.61 12.00 20.3 −1.28 15.3 0.466  
  1. aInterruptions in rhGH administration caused by orthopedic treatment